Global University Venturing

Backed by Research Institute of Tsinghua University in Shenzhen, CoWin Biosciences supplies biological reagents for diagnostics and research applications.

QuantaMatrix is targeting $17.80 to $22.30 per share under a regulation permitting a listing on the basis of growth and technology potential.

After the announcement of Warren Buffett’s bet on Japan’s largest trading houses, we take a brief look at how they have been doing on the corporate venturing arena.

UT Southwestern-linked CNS disease drug developer Taysha has filed to raise up to $100m in an IPO, just weeks after its $96m series B.

The Harvard-aligned firm surpassed its $100m target in a signal it has moved beyond the management rift that almost derailed its precursor.

Stanford spinout QuantumScape is set to merge with NYSE-listed Kensington Capital Acquisition in a $700m deal that will value the combined company at $3.3bn.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Notre Dame's commercialisation hub will help Saint Mary's College accelerate its tech transfer and entrepreneurship output.

University of Utah robotics spinout Sarcos has will use the funding for the commercial manufacturing of its industrial exoskeleton product.

UVC Partners has backed what appears to be financial document processing software company Hypatos's first funding round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.